Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients

In rheumatoid arthritis (RA), the identification of biomarkers to adjust treatment intensity and to correctly diagnose the disease in early stages still constitutes a challenge and, as such, novel biomarkers are needed. We proposed that autoantibodies (aAbs) against CD26 (DPP4) might have both etiol...

Descripción completa

Detalles Bibliográficos
Autores principales: Cordero, Oscar J., Viéitez, Irene, Altabás, Irene, Nuño-Nuño, Laura, Villalba, Alejandro, Novella-Navarro, Marta, Peiteado, Diana, Miranda-Carús, María-Eugenia, Balsa, Alejandro, Varela-Calviño, Rubén, Gomez-Tourino, Iria, Pego-Reigosa, José M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933303/
https://www.ncbi.nlm.nih.gov/pubmed/35304639
http://dx.doi.org/10.1007/s00005-022-00649-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933303/
https://www.ncbi.nlm.nih.gov/pubmed/35304639
http://dx.doi.org/10.1007/s00005-022-00649-6

Ejemplares similares